Antiretroviral News and Research

RSS

Ottawa researchers use viruses to target and destroy HIV

While Ottawa researchers are known for their work on cancer-fighting viruses, one team is applying these viruses to a new target: HIV.

19 Dec 2017

Study finds social stigma as barrier to successful treatment of children with HIV in Ethiopia

The social stigma surrounding HIV is still strong in many parts of the world. Children living with HIV in Ethiopia are at high risk of receiving inadequate treatment - or no treatment at all - on account of deeply rooted prejudice.

14 Dec 2017

IPM begins first clinical trial of vaginal rings to prevent HIV in women

The nonprofit International Partnership for Microbicides announced today the start of the first clinical trial of vaginal rings designed to slowly release the antiretroviral drug dapivirine over three months to prevent HIV in women.

13 Dec 2017

Survey shows prevalence of diarrhea in people living with HIV

Napo Pharmaceuticals, Inc., a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc., today released the results of a survey of 350 people living with HIV and AIDS on "Talking to Your Doctor About Symptoms".

13 Dec 2017

Chemical found in marijuana could help HIV patients maintain their mental function

A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.

12 Dec 2017

Study: Unusual neuroinflammation may underlie cognitive problems in cART-treated HIV patients

Although combination antiretroviral therapy (cART) has improved survival of patients infected with HIV and has reduced the incidence of severe neurologic complications, almost half of cART-treated HIV patients experience some degree of neurocognitive impairment (neuroHIV).

8 Dec 2017

WHO certifies elimination of mother-to-child HIV and syphilis transmission in six Caribbean territories

Anguilla, Antigua and Barbuda, Bermuda, Cayman Islands, Montserrat and Saint Kitts and Nevis were today certified by the World Health Organization as having eliminated mother-to-child transmission of HIV and syphilis.

5 Dec 2017

New dual-purpose drug delivery device to be developed for HIV and pregnancy prevention

In sub-Saharan Africa, women have among the highest fertility rates in the world. Unfortunately, they are also disproportionately at risk for HIV, a leading cause of illness and death among women of reproductive age.

30 Nov 2017

HIV directly impacts the brain in early stages of infection

Stellenbosch University researchers have discovered that the human immunodeficiency virus (HIV) directly impacts the brain in the early stages of the infection.

30 Nov 2017

U.S.-funded global effort appears to reduce incidence of new HIV infections

A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine.

30 Nov 2017

Immediate ART treatment following HIV diagnosis increases retention in care, study suggests

Starting antiretroviral therapy immediately following an HIV diagnosis dramatically improves retention in clinical HIV care, according to a study led by a Boston University School of Public Health researcher.

29 Nov 2017

New HIV prevention guidelines from Canada released

New guidelines for Canada have been published in the Canadian Medical Association Journal online this week that outline the use of new anti-HIV medications among high risk populations who are at risk of contracting HIV from getting the dreaded infection. These new guidelines aim to provide the clinicians with resources and support he added.

27 Nov 2017

New Canadian guideline outlines cost-effective strategies to prevent HIV in high-risk population

A new Canadian guideline outlines how new biomedical strategies to prevent HIV infection can best be used in high-risk populations both before and after exposure to the virus.

27 Nov 2017

Study highlights importance of reinforcing sexual risk-reduction messages for older women with HIV

A new study that compared HIV-positive women over 50 years of age with their younger HIV-infected cohorts found that while the older women were less likely to be sexually active and to report condomless sex with a male partner, those who were sexually active were not as likely to undergo screening for gonorrhea, chlamydia, or syphilis than their younger counterparts.

14 Nov 2017

New category of immunotherapy appears safe to use in patients with both cancer and HIV

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.

7 Nov 2017

Research shows high risk for cardiovascular and kidney disease in people with HIV

HIV patients and their doctors are urged to be more aware of the additional health risks associated with treated HIV infection. This follows new research that shows HIV patients at high risk for a heart attack or stroke are also at substantially greater risk for chronic kidney disease and vice versa.

7 Nov 2017

Study: PrEP program for men who have sex with men could lead to long-term cost savings

Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, and could help to prevent up to one in four cases of HIV, according to a study published in The Lancet Infectious Diseases journal.

19 Oct 2017

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union Notified Body.

12 Oct 2017

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.

10 Oct 2017

Scientists develop synthetic molecule effective at kicking and killing HIV

Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly reduce the chance of transmission from person to person.

5 Oct 2017

Antiretroviral News and Research

Ottawa researchers use viruses to target and destroy HIV

Study finds social stigma as barrier to successful treatment of children with HIV in Ethiopia

IPM begins first clinical trial of vaginal rings to prevent HIV in women

Survey shows prevalence of diarrhea in people living with HIV

Chemical found in marijuana could help HIV patients maintain their mental function

Study: Unusual neuroinflammation may underlie cognitive problems in cART-treated HIV patients

WHO certifies elimination of mother-to-child HIV and syphilis transmission in six Caribbean territories

New dual-purpose drug delivery device to be developed for HIV and pregnancy prevention

HIV directly impacts the brain in early stages of infection

U.S.-funded global effort appears to reduce incidence of new HIV infections

Immediate ART treatment following HIV diagnosis increases retention in care, study suggests

New HIV prevention guidelines from Canada released

New Canadian guideline outlines cost-effective strategies to prevent HIV in high-risk population

Study highlights importance of reinforcing sexual risk-reduction messages for older women with HIV

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Research shows high risk for cardiovascular and kidney disease in people with HIV

Study: PrEP program for men who have sex with men could lead to long-term cost savings

World’s only Atomo HIV Self Test receives CE Marking from European Union Notified Body

Trial reveals value of tuberculosis chemoprophylaxis in HIV-infected people

Scientists develop synthetic molecule effective at kicking and killing HIV

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News